KMTS
Income statement / Annual
Last year (2026), Kestra Medical Technologies Ltd.'s total revenue was $95.13 M,
an increase of 59.04% from the previous year.
In 2026, Kestra Medical Technologies Ltd.'s net income was -$131.61 M.
See Kestra Medical Technologies Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
| Period Ended |
04/30/2026 |
04/30/2025 |
04/30/2024 |
04/30/2023 |
| Operating Revenue |
$95.13 M |
$59.82 M |
$27.81 M |
$7.63 M |
| Cost of Revenue |
$46.26 M
|
$35.61 M
|
$27.45 M
|
$18.28 M
|
| Gross Profit |
$48.86 M
|
$24.21 M
|
$362.00 K
|
-$10.65 M
|
| Gross Profit Ratio |
0.51
|
0.4
|
0.01
|
-1.4
|
| Research and Development Expenses |
$19.48 M
|
$15.65 M
|
$15.49 M
|
$15.76 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$29.25 M
|
$19.10 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$40.68 M
|
$34.92 M
|
| Selling, General & Administrative Expenses |
$164.12 M
|
$114.94 M
|
$69.94 M
|
$54.01 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$183.60 M
|
$130.59 M
|
$85.43 M
|
$69.77 M
|
| Cost And Expenses |
$229.87 M
|
$166.19 M
|
$112.88 M
|
$88.05 M
|
| Interest Income |
$8.35 M
|
$3.20 M
|
$0.00
|
$0.00
|
| Interest Expense |
$7.55 M
|
$7.73 M
|
$6.23 M
|
$5.63 M
|
| Depreciation & Amortization |
-$4.40 M
|
$7.97 M
|
$11.56 M
|
$4.86 M
|
| EBITDA |
-$150.04 M |
-$97.98 M |
-$76.31 M |
-$73.74 M |
| EBITDA Ratio |
-1.58
|
-1.64
|
-2.74
|
-9.66
|
| Operating Income Ratio |
-1.42
|
-1.78
|
-3.06
|
-10.54
|
| Total Other Income/Expenses Net |
$3.42 M
|
-$7.30 M
|
-$9.03 M
|
-$3.80 M
|
| Income Before Tax |
-$131.32 M
|
-$113.68 M
|
-$94.10 M
|
-$84.22 M
|
| Income Before Tax Ratio |
-1.38
|
-1.9
|
-3.38
|
-11.04
|
| Income Tax Expense |
$294.00 K
|
$135.00 K
|
$24.00 K
|
$15.00 K
|
| Net Income |
-$131.61 M
|
-$113.81 M
|
-$94.12 M
|
-$84.24 M
|
| Net Income Ratio |
-1.38
|
-1.9
|
-3.38
|
-11.04
|
| EPS |
-2.43 |
-5.13 |
-2.04 |
-1.75 |
| EPS Diluted |
-2.43 |
-5.13 |
-2.04 |
-1.75 |
| Weighted Average Shares Out |
$58.40 M
|
$49.53 M
|
$49.53 M
|
$49.53 M
|
| Weighted Average Shares Out Diluted |
$58.40 M
|
$49.53 M
|
$49.53 M
|
$49.53 M
|
| Link |
|
|
|
|
